Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2014; 20(5): 1332-1339
Published online Feb 7, 2014. doi: 10.3748/wjg.v20.i5.1332
Published online Feb 7, 2014. doi: 10.3748/wjg.v20.i5.1332
Table 1 Information of colorectal cancer patients and healthy controls n (%)
| Colorectal cancer (n = 20) | Healthy controls (n = 20) | |
| Gender | ||
| Male | 10 (50) | 14 (70) |
| Female | 10 (50) | 6 (30) |
| Age group (yr) | ||
| 46-55 | 5 (25) | 5 (25) |
| 56-65 | 3 (15) | 4 (20) |
| 66-75 | 6 (30) | 7 (35) |
| ≥ 75 | 6 (30) | 4 (20) |
| Location of tumor | ||
| Ascending colon | 6 (30) | - |
| Transverse colon | 1 (5) | - |
| Descending colon | 6 (30) | - |
| Rectum | 7 (35) | - |
| Tumor stage (TNM) | ||
| I | 2 (10) | - |
| II | 7 (35) | - |
| III | 9 (45) | - |
| IV | 2 (10) | - |
- Citation: Wang HP, Wang YY, Pan J, Cen R, Cai YK. Evaluation of specific fecal protein biochips for the diagnosis of colorectal cancer. World J Gastroenterol 2014; 20(5): 1332-1339
- URL: https://www.wjgnet.com/1007-9327/full/v20/i5/1332.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i5.1332